Unicycive Therapeutics, Inc.
UNCY
$6.93
-$0.19-2.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.86% | 31.99% | -46.56% | -59.60% | 169.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 68.63% | 42.57% | 278.51% | 176.82% | 14.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 24.71% | 28.24% | 41.41% | 171.97% | 188.92% |
| Total Current Assets | 58.20% | 33.24% | -32.98% | -47.08% | 130.97% |
|
|
|||||
| Total Current Assets | 58.20% | 33.24% | -32.98% | -47.08% | 130.97% |
| Net Property, Plant & Equipment | -75.83% | -61.10% | -27.51% | -15.23% | -9.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 55.16% | 31.20% | -32.90% | -46.65% | 123.16% |
|
|
|||||
| Total Accounts Payable | -63.80% | 74.64% | -47.35% | 12.66% | 26.10% |
| Total Accrued Expenses | -57.24% | -7.69% | -30.56% | 16.70% | 10.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -79.26% | -51.11% | 13.61% | 59.77% | 72.48% |
| Total Finance Division Other Current Liabilities | -10.67% | 43.44% | 25.60% | -57.90% | 44.18% |
| Total Other Current Liabilities | -10.67% | 43.44% | 25.60% | -57.90% | 44.18% |
| Total Current Liabilities | -21.48% | 25.55% | 3.67% | -44.93% | 37.56% |
|
|
|||||
| Total Current Liabilities | -21.48% | 25.55% | 3.67% | -44.93% | 37.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -74.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.86% | 22.44% | 1.54% | -45.60% | 34.65% |
|
|
|||||
| Common Stock & APIC | 45.37% | 40.00% | 103.24% | 83.41% | 78.98% |
| Retained Earnings | -26.22% | -41.90% | -41.64% | -17.77% | -56.91% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 306.37% | 34.58% | 210.66% | 146.09% | 295.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 306.37% | 34.58% | 210.66% | 146.09% | 295.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 306.37% | 34.58% | -47.58% | -48.13% | 295.09% |
|
|
|||||